X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs MERCK LTD - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA MERCK LTD ABBOTT INDIA/
MERCK LTD
 
P/E (TTM) x 42.0 34.2 122.8% View Chart
P/BV x 10.5 3.8 274.0% View Chart
Dividend Yield % 0.6 0.7 86.6%  

Financials

 ABBOTT INDIA   MERCK LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
MERCK LTD
Dec-16
ABBOTT INDIA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs6,0151,060 567.5%   
Low Rs3,707623 595.0%   
Sales per share (Unadj.) Rs1,236.9632.4 195.6%  
Earnings per share (Unadj.) Rs122.245.7 267.3%  
Cash flow per share (Unadj.) Rs129.062.3 207.0%  
Dividends per share (Unadj.) Rs35.0011.00 318.2%  
Dividend yield (eoy) %0.71.3 55.1%  
Book value per share (Unadj.) Rs521.2388.8 134.1%  
Shares outstanding (eoy) m21.2516.60 128.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.91.3 295.4%   
Avg P/E ratio x39.818.4 216.1%  
P/CF ratio (eoy) x37.713.5 279.1%  
Price / Book Value ratio x9.32.2 430.9%  
Dividend payout %28.624.1 119.1%   
Avg Mkt Cap Rs m103,29613,969 739.5%   
No. of employees `0003.01.6 186.7%   
Total wages/salary Rs m3,3701,487 226.7%   
Avg. sales/employee Rs Th8,891.86,631.9 134.1%   
Avg. wages/employee Rs Th1,140.0939.2 121.4%   
Avg. net profit/employee Rs Th878.3479.4 183.2%   
INCOME DATA
Net Sales Rs m26,28410,498 250.4%  
Other income Rs m504242 208.1%   
Total revenues Rs m26,78910,741 249.4%   
Gross profit Rs m3,6651,135 322.9%  
Depreciation Rs m144276 52.4%   
Interest Rs m80-   
Profit before tax Rs m4,0171,102 364.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,421343 413.9%   
Profit after tax Rs m2,596759 342.1%  
Gross profit margin %13.910.8 129.0%  
Effective tax rate %35.431.1 113.6%   
Net profit margin %9.97.2 136.6%  
BALANCE SHEET DATA
Current assets Rs m14,4466,410 225.4%   
Current liabilities Rs m4,7258,828 53.5%   
Net working cap to sales %37.0-23.0 -160.5%  
Current ratio x3.10.7 421.1%  
Inventory Days Days5158 89.1%  
Debtors Days Days2038 50.9%  
Net fixed assets Rs m1,1131,406 79.1%   
Share capital Rs m213166 128.0%   
"Free" reserves Rs m10,8086,286 171.9%   
Net worth Rs m11,0766,455 171.6%   
Long term debt Rs m00-   
Total assets Rs m16,2418,828 184.0%  
Interest coverage x497.0NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.61.2 136.1%   
Return on assets %16.08.6 186.6%  
Return on equity %23.411.8 199.4%  
Return on capital %36.317.1 212.8%  
Exports to sales %0.68.3 7.4%   
Imports to sales %12.621.0 60.1%   
Exports (fob) Rs m162869 18.6%   
Imports (cif) Rs m3,3222,209 150.4%   
Fx inflow Rs m268959 28.0%   
Fx outflow Rs m3,9272,612 150.4%   
Net fx Rs m-3,659-1,653 221.4%   
CASH FLOW
From Operations Rs m2,5141,070 234.9%  
From Investments Rs m-800-750 106.6%  
From Financial Activity Rs m-803-150 536.0%  
Net Cashflow Rs m912171 533.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.8 144.8%  
Indian inst/Mut Fund % 7.9 18.2 43.4%  
FIIs % 0.1 1.0 10.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 29.1 58.8%  
Shareholders   18,270 28,591 63.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   CIPLA  PFIZER  ALKEM LABORATORIES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 19, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - SANOFI INDIA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS